Gincy George

1.1k total citations
24 papers, 722 citations indexed

About

Gincy George is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gincy George has authored 24 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gincy George's work include Prostate Cancer Treatment and Research (8 papers), Hormonal and reproductive studies (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Gincy George is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Hormonal and reproductive studies (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Gincy George collaborates with scholars based in United Kingdom, Sweden and United States. Gincy George's co-authors include Mieke Van Hemelrijck, Beth Russell, Aida Santaolalla, Charlotte Moss, Sophie Papa, Andrew Cope, Prokar Dasgupta, Kamran Ahmed, Anastasia Martin and Robert Stewart and has published in prestigious journals such as Annals of Oncology, International Journal of Cancer and European Urology.

In The Last Decade

Gincy George

23 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gincy George United Kingdom 12 248 221 178 123 103 24 722
Junwei Su China 12 285 1.1× 167 0.8× 137 0.8× 107 0.9× 122 1.2× 48 722
Rohit Gosain United States 14 146 0.6× 389 1.8× 133 0.7× 95 0.8× 157 1.5× 28 699
Gerhard Schillinger Germany 8 315 1.3× 178 0.8× 238 1.3× 164 1.3× 86 0.8× 16 766
Eric J. Duval United States 7 690 2.8× 196 0.9× 334 1.9× 144 1.2× 79 0.8× 10 1.1k
Yihui Huang China 14 285 1.1× 117 0.5× 158 0.9× 43 0.3× 58 0.6× 43 607
Margaret Teng Singapore 11 273 1.1× 121 0.5× 157 0.9× 51 0.4× 278 2.7× 25 771
Zhong Lü China 10 541 2.2× 312 1.4× 305 1.7× 92 0.7× 122 1.2× 19 1.1k
Xi Zhou China 11 210 0.8× 89 0.4× 114 0.6× 81 0.7× 98 1.0× 24 641
Wanlin Jiang United States 8 391 1.6× 153 0.7× 210 1.2× 50 0.4× 77 0.7× 13 584
Yunlei Deng China 8 554 2.2× 216 1.0× 287 1.6× 110 0.9× 127 1.2× 11 878

Countries citing papers authored by Gincy George

Since Specialization
Citations

This map shows the geographic impact of Gincy George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gincy George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gincy George more than expected).

Fields of papers citing papers by Gincy George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gincy George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gincy George. The network helps show where Gincy George may publish in the future.

Co-authorship network of co-authors of Gincy George

This figure shows the co-authorship network connecting the top 25 collaborators of Gincy George. A scholar is included among the top collaborators of Gincy George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gincy George. Gincy George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
George, Gincy, Beth Russell, Anne Rigg, A C C Coolen, & Mieke Van Hemelrijck. (2023). Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?. PubMed. Volume 14. 95–100.
2.
George, Gincy, Hans Garmo, Jan Adolfsson, et al.. (2023). Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of Oncology. 2023. 1–7. 1 indexed citations
3.
White, Benjamin, Brian Rous, Kandiah Chandrakumaran, et al.. (2022). Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study. The Lancet Regional Health - Europe. 23. 100510–100510. 81 indexed citations
4.
Boyle, Jemma M., Christopher Frampton, Elizabeth Harvey-Jones, et al.. (2021). Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study. European Journal of Cancer. 155. 136–144. 26 indexed citations
5.
Fox, Louis, Charlotte Moss, Gincy George, et al.. (2021). Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review. BMJ Open. 11(10). e046052–e046052. 1 indexed citations
6.
Rammant, Elke, Gincy George, Beth Russell, et al.. (2021). The incidence and prevalence of upper tract urothelial carcinoma: a systematic review. BMC Urology. 21(1). 110–110. 40 indexed citations
7.
Light, Alexander, Peter Gilling, Gincy George, et al.. (2021). Erectile Function Following Surgery for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials. European Urology. 80(2). 174–187. 6 indexed citations
8.
George, Gincy, Sarah Rudman, Zoe Moon, et al.. (2021). Qualitative Analysis of Interviews and Focus Groups Exploring Factors Contributing to Adherence to GnRH Agonists in Men with Prostate Cancer. Seminars in Oncology Nursing. 38(4). 151236–151236. 4 indexed citations
9.
Brunckhorst, Oliver, Anastasia Martin, Gincy George, et al.. (2020). Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies. Prostate Cancer and Prostatic Diseases. 24(2). 281–289. 77 indexed citations
10.
George, Gincy, Sam Sollie, Debra H. Josephs, et al.. (2020). Association of Serum Immunoglobulin Levels with Solid Cancer: A Systematic Review and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 29(3). 527–538. 16 indexed citations
11.
Russell, Beth, Charlotte Moss, Gincy George, et al.. (2020). Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. ecancermedicalscience. 14. 1022–1022. 323 indexed citations
12.
George, Gincy, Hans Garmo, Lucie‐Marie Scailteux, et al.. (2020). Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases. International Journal of Cancer. 148(9). 2203–2211. 28 indexed citations
13.
George, Gincy, Hans Garmo, Sarah Rudman, et al.. (2019). Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden. Scandinavian Journal of Urology. 54(1). 20–26. 15 indexed citations
14.
George, Gincy, Lucie‐Marie Scailteux, Hans Garmo, et al.. (2019). Real‐world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases. Fundamental and Clinical Pharmacology. 33(4). 479–499. 3 indexed citations
15.
George, Gincy, Lucie‐Marie Scailteux, Hans Garmo, et al.. (2018). The risk of cardiovascular disease following GnRH agonists versus antagonists: Real-world evidence from four European countries. European Urology Supplements. 17(2). e1850–e1850. 1 indexed citations
16.
Devlies, Wout, Aida Santaolalla, Fidelma Cahill, et al.. (2017). King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB). BMC Cancer. 17(1). 784–784. 11 indexed citations
17.
Crawley, Danielle, Ashish Chandra, Massimo Loda, et al.. (2017). Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer. BMC Cancer. 17(1). 494–494. 17 indexed citations
18.
Crawley, Danielle, Massimo Loda, Cheryl Gillett, et al.. (2016). Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer. Annals of Oncology. 27. vi261–vi261. 2 indexed citations
19.
Cahill, Fidelma, et al.. (2016). Research engagement among black men with prostate cancer. ecancermedicalscience. 10. 695–695. 10 indexed citations
20.
Bosco, Cecilia, Gabriele Cozzi, Netty Kinsella, et al.. (2016). Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience. ecancermedicalscience. 10. 633–633. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026